First-in-Human Study of GM-60106 in Healthy Adults and Otherwise Healthy Adults With an Increased Body Mass Index and Markers of Non-Alcoholic Fatty Liver Disease
Clinical trial NCT05517564 · UNKNOWN
Trial details
- NCT number
- NCT05517564
- Sponsor
- JD Bioscience Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2023-02-28
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.